2012Chinese Journal of ArteriosclerosisRequires access

Effects of Rosuvastatin Lowering Blood Pressure in Hypertensive Patients

Lin Chen

Open publisher page 0 citations

Abstract

AimTo determine whether rosuvastatin lowers blood pressure(BP) in hypertension with hyperlipidemia patients.Methods52 cases of hypertension with hyperlipidemia patients were divided into treatment group(using rosuvastation 10 mg/L + candesartan 8 mg/d) and control group(only using candesartan 8 mg/d).Observed for six months,the efficacy of blood pressure control was compared.ResultsSystolic blood pressure(SBP) fell by an average of 10.2 mmHg in the treatment group,SBP fell by an average of 7.5 mmHg in the control group(P0.05).Pulse pressure(PP) fell by an average of 6 mmHg in the treatment group,PP fell by an average of 3 mmHg in the control group(P0.05).Diastolic blood pressure(DBP) fell by an average of 4.9 mmHg in the treatment group,DBP fell by an average of 4.2 mmHg in the control group(P0.05).ConclusionsRosuvastation+candesartan had a significant effect on lowering SBP and PP in hypertension with hyperlipidemia patients campared with only using candesartan,but had no effect on DBP.

About this research paper

What this paper is about

AimTo determine whether rosuvastatin lowers blood pressure(BP) in hypertension with hyperlipidemia patients.Methods52 cases of hypertension with hyperlipidemia patients were divided into treatment group(using rosuvastation 10 mg/L + candesartan 8 mg/d) and control group(only using candesartan 8 mg/d).Observed for six months,the efficacy of blood pressure control was compared.ResultsSystolic blood pressure(SBP) fell by an average of 10.2 mmHg in the treatment group,SBP fell by an average of 7.5 mmHg in the control group(P0.05).Pulse pressure(PP) fell by an average of 6 mmHg in the treatment group,PP fell by an average of 3 mmHg in the control group(P0.05).Diastolic blood pressure(DBP) fell by an average of 4.9 mmHg in the treatment group,DBP fell by an average of 4.2 mmHg in the control group(P0.05).ConclusionsRosuvastation+candesartan had a significant effect on lowering SBP and PP in hypertension with hyperlipidemia patients campared with only using candesartan,but had no effect on DBP.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AimTo determine whether rosuvastatin lowers blood pressure(BP) in hypertension with hyperlipidemia patients.Methods52 cases of hypertension with hyperlipidemia patients were divided into treatment group(using rosuvastation 10 mg/L + candesartan 8 mg/d) and control group(only using candesartan 8 mg/d).Observed for six months,the efficacy of blood pressure control was compared.ResultsSystolic blood pressure(SBP) fell by an average of 10.2 mmHg in the treatment group,SBP fell by an average of 7.5 mmHg in the control group(P0.05).Pulse pressure(PP) fell by an average of 6 mmHg in the treatment group,PP fell by an average of 3 mmHg in the control group(P0.05).Diastolic blood pressure(DBP) fell by an average of 4.9 mmHg in the treatment group,DBP fell by an average of 4.2 mmHg in the control group(P0.05).ConclusionsRosuvastation+candesartan had a significant effect on lowering SBP and PP in hypertension with hyperlipidemia patients campared with only using candesartan,but had no effect on DBP.

Key concepts: Candesartan, Hyperlipidemia, Blood pressure, Medicine, Internal medicine, Rosuvastatin, Pulse pressure, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Rosuvastatin Lowering Blood Pressure in Hypertensive Patients — Research Paper | ScholarLens